fda glp-1 compounding enforcement september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our US FDA tightens control over

Ro works with thoroughly vetted compounding partners who source the active pharmaceutical ingredients (API) used in the compounded medication only from FDA-registered manufacturers

Always consult with a healthcare professional before beginning any new peptide or supplement routine

Nutrients 8, 167

This sequence of reactions elucidates the transformation of methionine into cysteine through the transsulfuration pathway [35]

Legal to purchase in some cases doesn't mean safe to use, and it doesn't mean a dermatologist would ever recommend it

Glucagon-Like Peptide-1 (GLP-1) Medications: From Bench to Bedside From a surprising discovery in Gila-monster venom to todays headline-making weight-loss breakthroughs, glucagon-like peptide-1 (GLP-1) medications have transformed diabetes and obesity care in just two decades